Corcept Therapeutics
CORT
#2078
Rank
A$13.65 B
Marketcap
A$129.63
Share price
1.71%
Change (1 day)
40.71%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of September 2025 : A$9.57 Million

According to Corcept Therapeutics 's latest financial reports the company's total debt is A$9.57 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$11.15 M4931.3%
2023-12-31A$0.22 M-86.8%
2022-12-31A$1.67 M131.5%
2021-12-31A$0.72 M-78.13%
2020-12-31A$3.31 M-32.89%
2019-12-31A$4.94 M
2018-12-31N/A
2016-12-31A$20.34 M-0.97%
2015-12-31A$20.54 M78.39%
2014-12-31A$11.51 M78.85%
2013-12-31A$6.43 M152.49%
2012-12-31A$2.55 M
2010-12-31N/A-100%
2009-12-31A$0 M-70.55%
2008-12-31A$0.02 M-31.63%
2007-12-31A$0.03 M-37.74%
2006-12-31A$0.05 M-27.81%
2005-12-31A$0.07 M
2003-12-31A$0.7 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
A$68.94 B 720,173.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$76.84 B 802,683.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$48.20 B 503,548.95%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$63.99 B 668,453.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$91.60 B 956,930.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$62.28 B 650,639.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.46 B 4,725.34%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$0.18 B 1,785.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.90 B 9,403.63%๐Ÿ‡บ๐Ÿ‡ธ USA